Boehringer Ingelheim and Veeva: A data partnership for One Medicine

This video explores Boehringer Ingelheim's "One Medicine Platform" initiative, a strategic digital transformation project aimed at unifying development processes and data in a centralized platform. The discussion highlights the company's collaboration with Veeva Systems, leveraging the Veeva Development Cloud to accelerate novel medicine development, reduce complexity, and foster an innovative digital culture. Speakers from Boehringer Ingelheim and Veeva discuss the evolution of clinical data management from paper to digital, the future integration of electronic health records (EHRs) into trials, and the importance of data-enabled clinical trials for patients, sites, and sponsors. The conversation also touches upon the recent go-live of Veeva Vault Clinical Data Management Suite (CDMS) as a significant milestone, emphasizing the creation of a holistic ecosystem where data is automatically available across various Veeva Vaults (Clinical, Quality, RIM) for functions like patient recruitment, data visualization, and dashboards. The future of clinical trials is envisioned with an increasing variety of data sources, the need for data curators, and adherence to FAIR data principles (Findable, Accessible, Interoperable, Reusable).

Key Takeaways:

• Strategic Digital Transformation with Veeva: Boehringer Ingelheim is undertaking a comprehensive digital transformation with its "One Medicine Platform" initiative, leveraging the full Veeva Development Cloud ecosystem (CDMS, Clinical, Quality, RIM) to unify processes, centralize data, and accelerate drug development.
• Evolution of Clinical Data Management: The industry is moving beyond traditional EDC systems to integrate diverse data sources, including EHRs, wearables, and real-world data, demanding robust data engineering and integration capabilities to manage this "data treasure."
• Data-Driven Decision Making & Optimization: The core objective is to enable faster, more informed, and confident data-driven decisions across the entire drug development lifecycle, benefiting patients, sites, and sponsors by streamlining operations and reducing complexity.
• Holistic Data Ecosystem for Interoperability: The vision is to create an interconnected data landscape where clinical data is automatically available and shared across different functional vaults (e.g., patient recruitment, data visualization, dashboards), emphasizing the importance of FAIR data principles.
• Addressing Unmet Medical Needs: Advanced data management and technology solutions are crucial for enabling trials in complex and emerging therapeutic areas like personalized medicine, cell & gene therapy, and rare diseases, bringing trials to patients more effectively.
• Partnership and Cultural Shift: Successful digital transformation requires a strong partnership between technology providers and pharmaceutical companies, coupled with a commitment to not repeat past processes but to embrace new technologies and foster an innovative digital culture.
• Future Role of Data Curators: The increasing volume and variety of data will necessitate specialized roles like data curators to extract maximum value from collected data, ensuring it is findable, accessible, interoperable, and reusable.